Aprea Therapeutics, Inc. APRE
0.50 USD -0.03 (-5.11%)
At closeNov 10, 2026, 7:47 AM EST
0.52 +0.02 +4.03%
Pre-market · Nov 10, 7:47 AM ET
0.501 Day range 0.5336
0.41 52-week range 1.49
- YTD
- -41.27%
- 1 year
- -59.27%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 285.76K | 1.50M | 583.23K | 0 | 0 | |
| 285.76K | 1.50M | 583.23K | 0 | 0 | |
| -13.23M | -14.32M | -15.47M | -113.39M | -37.45M | |
| -12.60M | -12.96M | -14.29M | -112.66M | -37.13M | |
| -1.93 | -2.35 | -3.95 | -67.99 | -34.88 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.64M | 22.89M | 21.65M | 28.79M | 53.08M | |
| 15.93M | 23.98M | 22.65M | 30.16M | 56.82M | |
| 3.49M | 4.67M | 5.70M | 4.51M | 7.32M | |
| 12.44M | 19.31M | 16.95M | 25.64M | 49.51M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -12.89M | -13.56M | -12.18M | -25.01M | -37.69M | |
| 4.64M | 14.82M | 5.14M | 682.97K | 1.75M | |
| -8.25M | 1.25M | -7.13M | -24.33M | -35.94M |